How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?

  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?

  • Question on Document

    Please could medical professionals with relevant experience consider the list of outcomes in the evidence generation plan and provide feedback comments?

Evidence generation plan for HTG10887 Digital platforms to support preparation before and rehabilitation after primary elective hip or knee replacement surgery: early-use assessment

Open for comments Open until   Request commenting lead permission

We have updated this service so that members of the same organisation can now collaborate on a joint online response.

Read our blog to learn more.

2 Evidence gaps

This section describes the evidence gaps, why they need to be addressed and their relative importance for future committee decision making.

The committee will not be able to make a positive recommendation without the essential evidence gaps (see section 2.1) being addressed. The company can strengthen the evidence base by also addressing as many other evidence gaps (see section 2.2) as possible. This will help the committee to make a recommendation by ensuring it has a better understanding of the patient or healthcare system benefits of the technology.

2.1 Essential evidence for future committee decision making

Comparative effectiveness versus NHS current practice

To assess the effectiveness of the technologies, data comparing their clinical benefit with current practice in the NHS is needed to evaluate whether these technologies would add value.

The committee noted limited generalisability, lack of information on adverse events, and lack of sufficient comparative effectiveness evidence of the technologies and discussed that most NHS patients receive no face-to-face physiotherapy.

Healthcare resource use

There is limited evidence of the impact these technologies have on healthcare resource use. The committee discussed that the current evidence base was mostly comprised of assumptions and sparse data. Further data about the impact on vital outcomes such as length of stay, length and nature of hospital appointments, length and number of physiotherapy sessions, escalation to face-to-face review, and readmissions will support a robust assessment of cost effectiveness.

2.2 Evidence that further supports committee decision making

Patient engagement and adherence

Evidence on engagement and adherence is required to better understand how these technologies would be used in practice and which subgroups would be more likely to benefit from them. This information will also be useful to assess the levels of engagement with the technology and assess whether these can influence outcomes and healthcare costs.